For example, the triple PIM/PI3K/mTOR inhibitor IBL-302 was used to treat an N-myc expressing neuroblastoma PDX in vivo, in combination with reduced-dose Cisplatin chemotherapy, following extensive in vitro screening [79]. Here, MYCN is linked to neuroblastoma.